Kezar Life Sciences Inc (NAS:KZR)
$ 0.7739 0.0059 (0.77%) Market Cap: 56.34 Mil Enterprise Value: -105.60 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 28/100

Kezar Life Sciences Inc R&D Day Transcript

Mar 15, 2023 / 08:30PM GMT
Release Date Price: $4.61 (-11.00%)
Operator

Welcome to Kezar's Life Sciences 2023 Research and Development Day. Today's presentation will be followed by a question-and-answer session.

During the course of this call, Kezar will be making forward-looking statements based on current expectations. These forward-looking statements are subject to a number of risks and uncertainties, and actual results may differ materially from those described.

We encourage you to review the risk factors in our most recent Form 10-K filed with the US Securities and Exchange Commission and available on our website. All statements on this call are made as of today based on information currently available to us. Except as required by law, we disclaim any obligation to update such statements even if our views change.

With that, I would now like to hand the call over to John Fowler, Chief Executive Officer and Co-Founder of Kezar Life Sciences. Go ahead, John.

John Fowler
Kezar Life Sciences, Inc. - CEO & Co-founder

Thank you, operator, for the introduction, and really thank you to everyone who's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot